RBC Capital analyst Gregory Renza maintained a Buy rating on Amgen (AMGN – Research Report) yesterday and set a price target of $320.00. The ...

In a report released yesterday, Matthew Hedberg from RBC Capital maintained a Buy rating on Varonis Systems (VRNS – Research Report), with a ...

Bonnici was a managing director at RBC and led several high-profile deals across infrastructure and technology during his ...

RBC, Jefferies and BNP Paribas are well placed to make gains as HSBC retrenches after Deutsche Numis shows momentum ...

Find insight on BNP Paribas, UBS, Kasikornbank and more in the latest Market Talks covering Financial Services.

RBC Capital Markets adjusted its price target for Regeneron Pharmaceuticals (NASDAQ:REGN), reducing it to $1,045 from the previous target of $1,059. Despite the decrease, the firm maintained its ...

The three most recent ratings, from Morgan Stanley, RBC Capital and JPMorgan, have an average target of $233.33, implying a 3.32% upside for IBM. IBM Price Action: IBM stock closed the trading day ...

Citi (C), JPMorgan Chase (JPM), Goldman Sachs (GS), and Wells Fargo (WFC) report on Wednesday, while Bank of America (BAC) and Morgan Stanley (MS) release results on Thursday. RBC Capital markets ...

IBM's was the standout deal of the week — Reverse Yankee or otherwise in the single currency. The issuer priced a €3.5bn ...